glp 1 agonist for weight loss Comparing Ozempic, Wegovy and Other GLP-1 Drugs GLP-1 Agonists for Weight Loss:
Description
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are approved for type 2 diabetes (T2D), and some are also indicated for reduction of the risk of atherosclerotic CVD in T2D and for weight management
However, due to the widespread presence of anti-PEG antibodies and PEG complement activation in vivo, peglosanatide is limited to the suitable population
Blackman A, Foster GD, Zammit G, et al
The lancet Diabetes & endocrinology
Ditah I, Devaki P, Luma HN, et al
